Accelerate Development Of Reliable Fertility, Pregnancy, And Prenatal LFA Tests
Developing accurate lateral flow tests for reproductive health can be challenging. Issues like cross-reactivity, inconsistent sensitivity, and poor line clarity often lead to unreliable results and longer development cycles. These challenges are especially critical for hormones such as hCG, LH, FSH, Alpha-subunit, TSH, and AFP, where precision and reproducibility are essential for patient confidence and regulatory compliance.
Our Solution
Arista Biologicals, a Fortis Life Sciences company provides validated antibodies, antigens, and colloidal gold conjugates optimized for lateral flow immunoassays. Our components deliver sharp test/control lines, high specificity, and batch-to-batch consistency. By minimizing variability and enhancing signal stability, we help you accelerate development and scale production for point-of-care rapid diagnostics.
Why Choose Arista Biologicals
Validated for LFA applications to reduce development risk
Consistent performance across batches for reproducible results
Scalable supply options to support pilot runs through full-scale production
Partner with us to overcome common challenges in DOA rapid test development and bring reliable products to market faster
Download Our Fertility Flier
Challenges We Help Solve
Developing accurate fertility, pregnancy, and prenatal screening tests for lateral flow applications presents unique challenges for test developers. Cross-reactivity, poor line clarity and scalability often lead to unreliable results and extended development cycles, particularly for critical markers like hCG, LH, FSH, Alpha-subunit, TSH, and AFP in rapid tests.
Scalability and Consistency in Manufacturing
Signal Intensity and Readability
Cross-Reactivity with Structurally Similar Hormones
×
Key Markers
We deliver LFA-optimized antibodies, antigens, and colloidal gold conjugates engineered specifically for these reproductive hormone and prenatal screening rapid tests.
Human Chorionic Gonadotropin (hCG)
hCG is the cornerstone marker for pregnancy detection, requiring precise measurement across a wide concentration range to avoid false negatives caused by the hook effect. Our LFA-validated antibodies are optimized for lateral flow assays, delivering strong specificity and clear line intensity for reliable results.
Luteinizing Hormone (LH)
LH plays a critical role in ovulation prediction, making accurate detection essential for fertility monitoring. Our antibodies and antigens are engineered for high selectivity and consistent performance, supporting dependable results in home-use and professional fertility tests.
Follicle-Stimulating Hormone (FSH)
FSH measurement is key for assessing ovarian reserve and fertility status. Our matched pairs provide robust sensitivity and minimal cross-reactivity, ensuring accurate detection in lateral flow formats for rapid, user-friendly screening.
Alpha Subunit
The alpha subunit is common to several glycoprotein hormones, including hCG, LH, FSH, and TSH, making specificity a challenge. Our antibodies are rigorously validated to minimize cross-reactivity, enabling precise detection in complex hormone panels for reproductive health diagnostics.
Thyroid-Stimulating Hormone (TSH)
TSH screening is vital for prenatal care and thyroid function assessment. Our optimized antibody-antigen pairs deliver reliable sensitivity and strong signal clarity, helping manufacturers develop accurate and easy-to-read rapid tests for thyroid health.
Alpha-fetoprotein (AFP)
AFP is a critical biomarker in prenatal screening for fetal health and maternal risk assessment. Our high-affinity monoclonal pairs are designed for strong specificity and reduced interference, supporting accurate detection in point-of-care lateral flow assays.
Additional Resources
Control Line Systems For Lateral Flow Assays
5 Reasons For Selecting Antibodies And Antigens From Fortis For Your Lateral Flow Assay
Talk With An Expert
Trust our high-quality lateral flow assay antibodies, antigens, and conjugates to support reliable performance and ensure dependable results for the clinical decisions that rely on your assays.
